Tapewire

Nasdaq · USD

BMEA

Biomea Fusion, Inc.

Export transactions ↓
Tapewire entity
6606
SEC CIK
0001840439
Parsed reports
98

Last 12 months

Inside the activity.

4 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202530
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 10, 2026 Filed Jun 12, 2026 20:15 UTC
AGUIAR ERICDirector
GrantStock Option (Right to Buy) · Derivative 196,299 $0.00 Strike: $1.15 $0.00
Disclosure

SEC source: 0001193125-26-269469 · ownership.xml · derivative · entry 1

AGUIAR ERIC · CIK 0001262325 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 196,299

Underlying: Common Stock · 196,299 shares

Expires 2036-06-09

F1 · derivative.exercise_date: The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document
June 10, 2026 Filed Jun 12, 2026 16:15 UTC GrantStock Option (Right to Buy) · Derivative 196,299 $0.00 Strike: $1.15 $0.00
Disclosure

SEC source: 0001193125-26-269470 · ownership.xml · derivative · entry 1

Faust Elizabeth · CIK 0001572143 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 196,299

Underlying: Common Stock · 196,299 shares

Expires 2036-06-09

F1 · derivative.exercise_date: The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document
June 10, 2026 Filed Jun 12, 2026 20:15 UTC
Ray SumitaDirector
GrantStock Option (Right to Buy) · Derivative 196,299 $0.00 Strike: $1.15 $0.00
Disclosure

SEC source: 0001193125-26-269468 · ownership.xml · derivative · entry 1

Ray Sumita · CIK 0001579629 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 196,299

Underlying: Common Stock · 196,299 shares

Expires 2036-06-09

F1 · derivative.exercise_date: The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document
June 10, 2026 Filed Jun 12, 2026 20:15 UTC GrantStock Option (Right to Buy) · Derivative 173,711 $0.00 Strike: $1.15 $0.00
Disclosure

SEC source: 0001193125-26-269465 · ownership.xml · derivative · entry 1

Averill Julianne · CIK 0001903770 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 173,711

Underlying: Common Stock · 173,711 shares

Expires 2036-06-09

F1 · derivative.exercise_date: The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:15 UTC
Erdtmann Rainer MDirector · See Remarks
GrantStock Option (Right to Buy) · Derivative 452,512 $0.00 Strike: $1.49 $0.00
Disclosure

SEC source: 0001193125-26-142178 · ownership.xml · derivative · entry 1

Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 452,512

Underlying: Common Stock · 452,512 shares

Expires 2036-03-31

F1 · derivative.exercise_date: The option shall vest and become exercisable in 16 substantially equal quarterly installments after April 1, 2026, such that the award will be fully vested and exercisable on April 1, 2030, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 20:15 UTC
Hitchcock Michael J.M.Director · Interim CEO
GrantStock Option (Right to Buy) · Derivative 667,477 $0.00 Strike: $1.49 $0.00
Disclosure

SEC source: 0001193125-26-142177 · ownership.xml · derivative · entry 1

Hitchcock Michael J.M. · CIK 0001856674 · Director · Interim CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 667,477

Underlying: Common Stock · 667,477 shares

Expires 2036-03-31

F1 · derivative.exercise_date: The option shall vest and become exercisable in 16 substantially equal quarterly installments after April 1, 2026, such that the award will be fully vested and exercisable on April 1, 2030, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Read SEC document
December 31, 2025 Filed Feb 6, 2026 21:15 UTC
Erdtmann Rainer MDirector · See Remarks
GiftCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-041207 · ownership.xml · nonDerivative · entry 6

Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Indirect · By daughter

Disclosed balance after: 70,000

Read SEC document
December 31, 2025 Filed Feb 6, 2026 21:15 UTC
Erdtmann Rainer MDirector · See Remarks
GiftCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-041207 · ownership.xml · nonDerivative · entry 5

Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 572,427

Read SEC document
December 31, 2025 Filed Feb 6, 2026 21:15 UTC
Erdtmann Rainer MDirector · See Remarks
GiftCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-041207 · ownership.xml · nonDerivative · entry 4

Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Indirect · By son

Disclosed balance after: 70,000

Read SEC document
December 31, 2025 Filed Feb 6, 2026 21:15 UTC
Erdtmann Rainer MDirector · See Remarks
GiftCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-041207 · ownership.xml · nonDerivative · entry 3

Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 622,427

Read SEC document
December 31, 2025 Filed Feb 6, 2026 21:15 UTC
Erdtmann Rainer MDirector · See Remarks
GiftCommon Stock 50,600 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-041207 · ownership.xml · nonDerivative · entry 2

Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Indirect · By daughter

Disclosed balance after: 70,000

Read SEC document
December 31, 2025 Filed Feb 6, 2026 21:15 UTC
Erdtmann Rainer MDirector · See Remarks
GiftCommon Stock 50,600 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-041207 · ownership.xml · nonDerivative · entry 1

Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 672,427

Read SEC document
December 11, 2025 Filed Dec 15, 2025 21:15 UTC
Erdtmann Rainer MDirector · See Remarks
PurchaseCommon Stock 30,000 $1.43 $42,999.00
Disclosure

SEC source: 0001193125-25-319222 · ownership.xml · nonDerivative · entry 1

Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 723,027

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 21:15 UTC
Hitchcock Michael J.M.Director · Interim CEO
PurchaseCommon Stock 100,000 $0.99 $99,180.00
Disclosure

SEC source: 0001193125-25-308091 · ownership.xml · nonDerivative · entry 1

Hitchcock Michael J.M. · CIK 0001856674 · Director · Interim CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9828 to $1.0099, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Read SEC document
December 01, 2025 Filed Dec 2, 2025 21:15 UTC
Erdtmann Rainer MDirector · See Remarks
PurchaseCommon Stock 10,000 $1.05 $10,500.00
Disclosure

SEC source: 0001193125-25-305287 · ownership.xml · nonDerivative · entry 2

Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 693,027

Read SEC document
November 28, 2025 Filed Dec 2, 2025 21:15 UTC
Erdtmann Rainer MDirector · See Remarks
PurchaseCommon Stock 40,000 $1.10 $44,052.00
Disclosure

SEC source: 0001193125-25-305287 · ownership.xml · nonDerivative · entry 1

Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 683,027

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.09 to $1.1099, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Read SEC document
August 11, 2025 Filed Aug 13, 2025 20:15 UTC
Erdtmann Rainer MDirector · See Remarks
GrantStock Option (Right to Buy) · Derivative 1,246,989 $0.00 Strike: $1.53 $0.00
Disclosure

SEC source: 0000950170-25-108041 · ownership.xml · derivative · entry 12

Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,246,989

Underlying: Common Stock · 1,246,989 shares

Expires 2035-08-10

F5 · derivative.exercise_date: The option shall vest and become exercisable in 16 substantially equal quarterly installments after August 8, 2025, such that the award will be fully vested and exercisable on August 8, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Read SEC document
August 11, 2025 Filed Aug 13, 2025 20:15 UTC
Hitchcock Michael J.M.Director · Interim CEO
GrantStock Option (Right to Buy) · Derivative 916,434 $0.00 Strike: $1.53 $0.00
Disclosure

SEC source: 0000950170-25-108045 · ownership.xml · derivative · entry 1

Hitchcock Michael J.M. · CIK 0001856674 · Director · Interim CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 916,434

Underlying: Common Stock · 916,434 shares

Expires 2035-08-10

F1 · derivative.exercise_date: The option shall vest and become exercisable in 16 substantially equal quarterly installments after August 8, 2025, such that the award will be fully vested and exercisable on August 8, 2029, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Read SEC document
July 22, 2025 Filed Jul 24, 2025 20:15 UTC GrantStock Option (Right to Buy) · Derivative 241,177 $0.00 Strike: $1.82 $0.00
Disclosure

SEC source: 0000950170-25-098343 · ownership.xml · derivative · entry 1

Averill Julianne · CIK 0001903770 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 241,177

Underlying: Common Stock · 241,177 shares

Expires 2035-07-21

F1 · derivative.exercise_date: One thirty-sixth (1/36th) of the total number of shares subject to the stock option shall vest and become exercisable on each monthly anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Read SEC document
June 11, 2025 Filed Jun 13, 2025 20:02 UTC
Chen BihuaDirector · 10% owner
GrantStock Option (Right to Buy) · Derivative 91,970 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0000929638-25-002234 · form4.xml · derivative · entry 6

Chen Bihua · CIK 0001599214 · Director · 10% owner

Cormorant Global Healthcare Master Fund, LP · CIK 0001618442 · 10% owner

Cormorant Private Healthcare Fund III LP · CIK 0001817320 · 10% owner

Cormorant Asset Management, LP · CIK 0001583977 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,970

Underlying: Common Stock · 91,970 shares

Expires 2035-06-10

F5 · derivative.exercise_date: The options vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to Ms. Chen's continuing service to the Issuer through such vesting date.

F4 · ownership.direct: Stock options granted to Bihua Chen, in her capacity as a director of the Issuer.

Read SEC document
June 11, 2025 Filed Jun 13, 2025 20:15 UTC
AGUIAR ERICDirector
GrantStock Option (Right to Buy) · Derivative 91,970 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0000950170-25-086191 · ownership.xml · derivative · entry 1

AGUIAR ERIC · CIK 0001262325 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,970

Underlying: Common Stock · 91,970 shares

Expires 2035-06-10

F1 · derivative.exercise_date: The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document
June 11, 2025 Filed Jun 13, 2025 16:15 UTC GrantStock Option (Right to Buy) · Derivative 91,970 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0000950170-25-086193 · ownership.xml · derivative · entry 1

Faust Elizabeth · CIK 0001572143 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,970

Underlying: Common Stock · 91,970 shares

Expires 2035-06-10

F1 · derivative.exercise_date: The shares underlying the stock option will vest in full upon the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document
June 11, 2025 Filed Jun 13, 2025 20:15 UTC
Ray SumitaDirector
GrantStock Option (Right to Buy) · Derivative 91,970 $0.00 Strike: $2.50 $0.00
Disclosure

SEC source: 0000950170-25-086190 · ownership.xml · derivative · entry 1

Ray Sumita · CIK 0001579629 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 91,970

Underlying: Common Stock · 91,970 shares

Expires 2035-06-10

F1 · derivative.exercise_date: The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document
March 26, 2025 Filed Mar 28, 2025 20:15 UTC
Hitchcock Michael J.M.Director · Interim CEO
GrantStock Option (Right to Buy) · Derivative 350,000 $0.00 Strike: $2.52 $0.00
Disclosure

SEC source: 0000950170-25-046790 · ownership.xml · derivative · entry 1

Hitchcock Michael J.M. · CIK 0001856674 · Director · Interim CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 350,000

Underlying: Common Stock · 350,000 shares

Expires 2035-03-25

F1 · derivative.exercise_date: The option shall vest and become exercisable in twelve substantially equal monthly installments over a period of twelve months from March 25, 2025, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Read SEC document
January 31, 2025 Filed Aug 13, 2025 20:15 UTC
Erdtmann Rainer MDirector · See Remarks
GiftCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-108041 · ownership.xml · nonDerivative · entry 7

Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Indirect · By daughter

Disclosed balance after: 20,000

Read SEC document
January 31, 2025 Filed Aug 13, 2025 20:15 UTC
Erdtmann Rainer MDirector · See Remarks
GiftCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-108041 · ownership.xml · nonDerivative · entry 6

Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 643,027

Read SEC document
January 31, 2025 Filed Aug 13, 2025 20:15 UTC
Erdtmann Rainer MDirector · See Remarks
GiftCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-108041 · ownership.xml · nonDerivative · entry 5

Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Indirect · By son

Disclosed balance after: 20,000

Read SEC document
January 31, 2025 Filed Aug 13, 2025 20:15 UTC
Erdtmann Rainer MDirector · See Remarks
GiftCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-108041 · ownership.xml · nonDerivative · entry 4

Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 653,027

Read SEC document
January 31, 2025 Filed Aug 13, 2025 20:15 UTC
Erdtmann Rainer MDirector · See Remarks
GiftCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-108041 · ownership.xml · nonDerivative · entry 3

Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Indirect · By daughter

Disclosed balance after: 19,400

Read SEC document
January 31, 2025 Filed Aug 13, 2025 20:15 UTC
Erdtmann Rainer MDirector · See Remarks
GiftCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-108041 · ownership.xml · nonDerivative · entry 2

Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 663,027

Read SEC document
January 28, 2025 Filed Aug 13, 2025 20:15 UTC
Erdtmann Rainer MDirector · See Remarks
GiftCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-108041 · ownership.xml · nonDerivative · entry 1

Erdtmann Rainer M · CIK 0001455767 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 673,027

Read SEC document
November 30, 2024 Filed Dec 2, 2024 16:30 UTC
Valle FrancoChief Financial Officer
GrantCommon Stock 495 $6.15 $3,046.23
Disclosure

SEC source: 0000950170-24-132253 · ownership.xml · nonDerivative · entry 1

Valle Franco · CIK 0001699848 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,995

F1 · kind: These shares were acquired under the Biomea Fusion, Inc. 2021 Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased at a purchase price of 85% of the fair market value of the Issuer's common stock on November 29, 2024.

Read SEC document
September 30, 2024 Filed Oct 1, 2024 20:30 UTC PurchaseCommon Stock 10,000 $10.06 $100,600.00
Disclosure

SEC source: 0000950170-24-110858 · ownership.xml · nonDerivative · entry 1

Hitchcock Michael J.M. · CIK 0001856674 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,000

Read SEC document
June 12, 2024 Filed Jun 13, 2024 20:38 UTC
Chen BihuaDirector · 10% owner
GrantStock Option (right to buy) · Derivative 51,025 $0.00 Strike: $4.63 $0.00
Disclosure

SEC source: 0000929638-24-002175 · form4.xml · derivative · entry 5

Chen Bihua · CIK 0001599214 · Director · 10% owner

Cormorant Global Healthcare Master Fund, LP · CIK 0001618442 · 10% owner

Cormorant Private Healthcare Fund III LP · CIK 0001817320 · 10% owner

Cormorant Asset Management, LP · CIK 0001583977 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51.025

Underlying: Common Stock · 51,025 shares

Expires 2034-06-11

F5 · derivative.exercise_date: The options vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to Ms. Chen's continuing service to the Issuer through such vesting date.

F4 · ownership.direct: Stock options granted to Bihua Chen, in her capacity as a director of the Issuer.

Read SEC document
June 12, 2024 Filed Jun 13, 2024 20:30 UTC
AGUIAR ERICDirector
GrantStock Option (Right to Buy) · Derivative 51,025 $0.00 Strike: $4.63 $0.00
Disclosure

SEC source: 0000950170-24-073068 · ownership.xml · derivative · entry 1

AGUIAR ERIC · CIK 0001262325 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,025

Underlying: Common Stock · 51,025 shares

Expires 2034-06-11

F1 · derivative.exercise_date: The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document
June 12, 2024 Filed Jun 13, 2024 16:30 UTC GrantStock Option (Right to Buy) · Derivative 51,025 $0.00 Strike: $4.63 $0.00
Disclosure

SEC source: 0000950170-24-073074 · ownership.xml · derivative · entry 1

Faust Elizabeth · CIK 0001572143 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,025

Underlying: Common Stock · 51,025 shares

Expires 2034-06-11

F1 · derivative.exercise_date: The shares underlying the stock option will vest in full upon the earlier of (i) the first anniversary of the date of grant and (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document
June 12, 2024 Filed Jun 13, 2024 20:30 UTC
Ray SumitaDirector
GrantStock Option (Right to Buy) · Derivative 51,025 $0.00 Strike: $4.63 $0.00
Disclosure

SEC source: 0000950170-24-073075 · ownership.xml · derivative · entry 1

Ray Sumita · CIK 0001579629 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,025

Underlying: Common Stock · 51,025 shares

Expires 2034-06-11

F1 · derivative.exercise_date: The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document
June 12, 2024 Filed Jun 13, 2024 20:30 UTC GrantStock Option (Right to Buy) · Derivative 51,025 $0.00 Strike: $4.63 $0.00
Disclosure

SEC source: 0000950170-24-073069 · ownership.xml · derivative · entry 1

Hitchcock Michael J.M. · CIK 0001856674 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,025

Underlying: Common Stock · 51,025 shares

Expires 2034-06-11

F1 · derivative.exercise_date: The shares underlying the stock option will vest in full upon the earlier of (i) the one-year anniversary of the date of grant or (ii) immediately prior to the annual meeting of the Issuer's stockholders that occurs following the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.

Read SEC document
June 11, 2024 Filed Jun 12, 2024 16:30 UTC
Valle FrancoChief Financial Officer
PurchaseCommon Stock 12,509 $4.43 $55,361.08
Disclosure

SEC source: 0000950170-24-072494 · ownership.xml · nonDerivative · entry 2

Valle Franco · CIK 0001699848 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,500

F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.4199 to $4.4299, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Read SEC document
May 31, 2024 Filed Jun 12, 2024 16:30 UTC
Valle FrancoChief Financial Officer
GrantCommon Stock 4,448 $3.78 $16,824.56
Disclosure

SEC source: 0000950170-24-072494 · ownership.xml · nonDerivative · entry 1

Valle Franco · CIK 0001699848 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,991

F1 · kind: These shares were acquired under the Biomea Fusion, Inc. 2021 Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased at a purchase price of 85% of the fair market value of the Issuer's common stock on June 1, 2022.

Read SEC document
May 31, 2024 Filed Jun 12, 2024 20:30 UTC
Frias Juan PabloChief Medical Officer
GrantCommon Stock 349 $8.94 $3,120.76
Disclosure

SEC source: 0000950170-24-072493 · ownership.xml · nonDerivative · entry 1

Frias Juan Pablo · CIK 0001990665 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 349

F1 · kind: These shares were acquired under the Biomea Fusion, Inc. 2021 Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

F2 · price: In accordance with the ESPP, these shares were purchased at a purchase price of 85% of the fair market value of the Issuer's common stock on May 31, 2024.

Read SEC document
January 17, 2024 Filed Jan 18, 2024 16:30 UTC
Valle FrancoChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 145,245 $0.00 Strike: $14.44 $0.00
Disclosure

SEC source: 0000950170-24-005416 · ownership.xml · derivative · entry 1

Valle Franco · CIK 0001699848 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 145,245

Underlying: Common Stock · 145,245 shares

Expires 2034-01-16

F1 · derivative.exercise_date: The option shall vest and become exercisable in quarterly installments over four years, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Read SEC document
January 17, 2024 Filed Jan 18, 2024 21:30 UTC
Erdtmann Rainer MDirector · President and COO
GrantStock Option (Right to Buy) · Derivative 135,700 $0.00 Strike: $14.44 $0.00
Disclosure

SEC source: 0000950170-24-005415 · ownership.xml · derivative · entry 1

Erdtmann Rainer M · CIK 0001455767 · Director · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,700

Underlying: Common Stock · 135,700 shares

Expires 2034-01-16

F1 · derivative.exercise_date: The option shall vest and become exercisable in quarterly installments over four years, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Read SEC document
January 17, 2024 Filed Jan 18, 2024 21:30 UTC
Butler Thomas AndrewDirector · Chief Executive Officer · 10% owner
GrantStock Option (Right to Buy) · Derivative 407,502 $0.00 Strike: $14.44 $0.00
Disclosure

SEC source: 0000950170-24-005417 · ownership.xml · derivative · entry 1

Butler Thomas Andrew · CIK 0001857171 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 407,502

Underlying: Common Stock · 407,502 shares

Expires 2034-01-16

F1 · derivative.exercise_date: The option shall vest and become exercisable in quarterly installments over four years, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Read SEC document
January 17, 2024 Filed Jan 18, 2024 21:30 UTC
Frias Juan PabloChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 111,090 $0.00 Strike: $14.44 $0.00
Disclosure

SEC source: 0000950170-24-005414 · ownership.xml · derivative · entry 1

Frias Juan Pablo · CIK 0001990665 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,090

Underlying: Common Stock · 111,090 shares

Expires 2034-01-16

F1 · derivative.exercise_date: The option shall vest and become exercisable in quarterly installments over four years, subject to the Reporting Person's continued service to the Issuer through each vesting date.

Read SEC document
December 29, 2023 Filed Jan 3, 2024 21:30 UTC
Erdtmann Rainer MDirector · President and COO
GiftCommon Stock 12,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-000956 · ownership.xml · nonDerivative · entry 7

Erdtmann Rainer M · CIK 0001455767 · Director · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 713,027

F1 · ownership.direct: Includes 76,059 shares held directly by the Reporting Person and the remaining shares are held directly by the Reporting Person through a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.

Read SEC document
December 29, 2023 Filed Jan 3, 2024 21:30 UTC
Erdtmann Rainer MDirector · President and COO
GiftCommon Stock 3,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-000956 · ownership.xml · nonDerivative · entry 6

Erdtmann Rainer M · CIK 0001455767 · Director · President and COO

10b5-1 filing: No plan indicated

Ownership: Indirect · By daughter

Disclosed balance after: 10,000

Read SEC document
December 29, 2023 Filed Jan 3, 2024 21:30 UTC
Erdtmann Rainer MDirector · President and COO
GiftCommon Stock 3,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-000956 · ownership.xml · nonDerivative · entry 5

Erdtmann Rainer M · CIK 0001455767 · Director · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 725,027

F1 · ownership.direct: Includes 76,059 shares held directly by the Reporting Person and the remaining shares are held directly by the Reporting Person through a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.

Read SEC document
December 29, 2023 Filed Jan 3, 2024 21:30 UTC
Erdtmann Rainer MDirector · President and COO
GiftCommon Stock 3,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-000956 · ownership.xml · nonDerivative · entry 4

Erdtmann Rainer M · CIK 0001455767 · Director · President and COO

10b5-1 filing: No plan indicated

Ownership: Indirect · By son

Disclosed balance after: 10,000

Read SEC document
December 29, 2023 Filed Jan 3, 2024 21:30 UTC
Erdtmann Rainer MDirector · President and COO
GiftCommon Stock 3,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-000956 · ownership.xml · nonDerivative · entry 3

Erdtmann Rainer M · CIK 0001455767 · Director · President and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 728,027

F1 · ownership.direct: Includes 76,059 shares held directly by the Reporting Person and the remaining shares are held directly by the Reporting Person through a family trust of which the Reporting Person is the trustee. The Reporting Person disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any. This report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.